October 29, 2001 – “Beljanski products”, herbal extracts, are said to attack cancer cells while preserving healthy cells. Non-toxic, they would also allow patients to endure chemotherapy and radiotherapy treatments much better and even make them more effective. Natural Source International, the company that manufactures and distributes these products, was in Quebec in October to give a series of conferences on the subject.
Small history
The history of Beljanski products is very complex: currently manufactured in the United States, they have never been approved as drugs in France, despite attempts to do so by Beljanski and his team. Yet according to Natural Source International, thousands of people use these treatments to treat their cancer under the supervision of certain doctors.
Mirko Beljanski, researcher in molecular biology at the Institut Pasteur in France for 30 years, published more than 130 works in scientific journals between 1949 and 2000; he died in 1998. During the 1970s, Professor Beljanski made pioneering hypotheses on the functioning of the genetic code, more specifically on the key role of RNA and on an enzyme called reverse transcriptase. However, his research was ignored by the French scientific community, in particular, because it went against the hypotheses accepted at the time in molecular biology: it was believed that DNA was the sole support of the genetic code of cell and that RNA was a simple messenger1. Beljanski’s hypotheses were nevertheless confirmed by American researchers during the 1980s: RNA can be transcribed into DNA using reverse transcriptase. This work will open up new perspectives on how cancer works. We understand, among other things, that the DNA of cancer cells is destabilized: the strands of the chains are mismatched (separated), which makes the cells fragile to attacks by certain carcinogenic agents and activates their replication: a vicious circle is then set in motion .1.
During his work, Beljanski is developing an analysis process (Oncotest) which allows him to detect in a few hours the carcinogenic potential of a substance at very low concentrations.2. Through this process, he identifies two plants whose alkaloids act selectively on the genes of cancer cells: by a mechanical process that tightens the links of mismatched DNA, they block the functioning of the enzymes of replication and transcription and cause the cancer cell death, without harming healthy cells3. This is interesting since the main problem with radiotherapy is that it destroys everything, even healthy cells.
Products and plants
Flavopereirine, taken from Pao pereira (an Amazonian tree), would act on all forms of cancer, while alstonine, taken from Rauwolfia (an African plant) would be more effective in cases of hormonal cancers. These two products, called Pao V and Rovol V respectively, would not cause any of the harmful and extremely unpleasant side effects of radiation and chemotherapy treatments and are even more effective when combined with them. Indeed, the extracts bind even better to cancerous DNA, because its destabilization is accentuated by these treatments.
Another product made from Gingko Biloba (different from the gingko supplements usually offered), Gingko V, is said to reduce fibrosis caused by radiation. Finally, Real Build, derived from the RNA of the E. Coli bacteria, would have the property of protecting cells during radiotherapy and chemotherapy treatments and therefore of greatly reducing the side effects of conventional treatments.
No study
Although 3,000 to 5,000 people are currently taking products (some under the supervision of doctors), no clinical or epidemiological study has been carried out to compare the results obtained with Beljanski products and conventional treatments. However sincere they may be, the testimonies of a few doctors and patients are not sufficient to obtain scientific endorsement. So far, Beljanski’s successors have not secured the necessary funding for these extremely expensive studies.
Expensive products
Beljanski products are made in the USA and sold by Natural Source International by Internet. They cost between $ 1.05 and $ 1.30 each and are considered a dietary supplement under US regulations. Depending on the treatment and the patient’s weight, the patient takes 6 to 12 capsules per day. The company is currently working on a synthetic molecule that would be more efficient and lower production costs, but this work will not be completed for three years. Beljanski’s successors also claim that their products can help people with AIDS, lupus and other autoimmune diseases.
Disputed situation
In the saga that has pitted Mirko Beljanski against medical authorities for many years, a verdict was handed down last spring for the illegal practice of pharmacy. Several people, including Ms. Monique Beljanski, the teacher’s widow, and patients, were sentenced to suspended prison terms and heavy fines. The lawyers said they wanted to appeal the decision. The ins and outs of this river trial are complex. Let’s sum it all up by saying that on the one hand, Beljanski’s successors are convinced that they have effective products in hand, but say they are grappling with adversaries using dubious maneuvers to sabotage the researcher’s work. On the other hand, Beljanski is criticized for having submitted incomplete files, which justified the rejection of the approval as a drug, for having opened multiple rather opaque commercial companies and for having encouraged patients to give up. their conventional treatments to take only the products in question.4 Note that currently, Beljanski’s successors recommend that patients continue their radiotherapy and chemotherapy treatments.
Françoise Ruby – PasseportSanté.net
Sources
Conference on Beljanski products organized by Natural Source International, October 11 in Montreal.
Nordiau C.-G, Beljanski M. Beljanski, an innovator in biomedicine. EVI Liberty Corp editions, New York, 2001.
Liberation, March 21, 2001. Widow Beljanski is prosecuted for illegally practicing pharmacy.http: //myweb.worldnet.net/~gonnet/beljanski.htm
Impatient, May 1990 and December 1994.
Schachter, Michael B. Mirko Beljanski Controversial Approach to Treating Cancer. http://www.mbschachter.com/mirko_beljanski.htm
1. Impatient, December 1994.
2. Impatient, May 1990.
3. Nordiau C.-G, Beljanski M. Beljanski, an innovator in biomedicine. EVI Liberty Corp editions, New York, 2001.
4. Release, March 21, 2001. Widow Beljanski is being prosecuted for illegally practicing pharmacy. Http://myweb.worldnet.net/~gonnet/beljanski.htm